Search for: "Teva Pharmaceutical" Results 401 - 420 of 1,423
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Sun Pharmaceuticals v. Eli Lilly: obviousness-type double patenting in the pharmaceutical context
2 Aug 2010, 5:00 am by Jason Rantanen
Teva, 518 F.3d 1353. [read post]
Patently-O - http://www.patentlyo.com/patent/
Florida Appellate Court Remands Defective Drug Case for Personal Jurisdiction Determination
3 Nov 2015, 9:36 am by Friedman, Rodman & Frank, P.A.
In Teva Pharmaceutical Industries v. [read post]
South Florida Personal Injury Lawyers Blog - http://www.southfloridapersonalinjurylawyers-blog.com/
Tuesday round-up
1 Apr 2014, 4:52 am by Amy Howe
  This blog’s Lyle Denniston covered the certiorari grant in Teva Pharmaceuticals USA v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Judge Bartle: Motion to Exclude Patent Law Expert GRANTED in Part
29 Sep 2010, 8:28 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
N.J. Chief Judge Bartle: Amgen Patents Not Invalid after Bench Trial
28 Jan 2011, 11:38 am by Andrew Russell
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
A Primer on Paragraph IV Certifications: Into the Belly of the Hatch-Waxman Beast Part 1
3 Apr 2013, 4:45 am by Eric Guttag
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Pharmacology Expert Witness & Cephalon Case
16 Jun 2015, 6:00 am
Teva Pharmaceutical Industries, Ltd. will make a total of $1.2B available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon’s illegal conduct. [read post]
Expert Witness Blog - http://www.expertwitnessblog.com/
St. Regis Mohawk Tribe Petitions Federal Circuit for En Banc Review of Panel Decision Voiding Sovereign Immunity in Inter Partes Review
21 Aug 2018, 9:58 pm by Patent Docs
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals... [read post]
Patent Docs - http://www.patentdocs.org/
Webinar on Diagnose & Treat Patent Claims
29 Sep 2018, 8:09 pm by Patent Docs
Teva Parenteral Medicines Inc. -- Vanda Pharmaceuticals Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
In re Couvaras (Fed. Cir. 2023)
27 Jun 2023, 7:32 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Judge Permits Two Controversial Opioid Sales Training Videos to Be Shown to Jury in New York State Opioid Trial
13 Dec 2021, 3:34 pm by Simmons Hanly Conroy
On Tuesday, Dec. 7, 2021, the jury in the New York State opioid trial viewed two controversial internal sales-training videos from Teva Pharmaceuticals that had previously been under seal. [read post]
Simmons Firm Law Blog - http://www.simmonsfirm.com/blog/
In order to allocate more resources to prevent the import of high risk defective drugs the FDA is testing a Secure Supply Chain Pilot Program that allows 13 pharmaceutical companies to have expedited entry for up to 5 drug products
19 Feb 2014, 6:57 am
• Teva Pharmaceutcials USA, Inc. [read post]
New York Personal Injury Attorneys Blog - http://www.newyorkpersonalinjuryattorneysblog.com/
Untitled
8 Jan 2010, 12:01 pm
Patent Infringement LawsuitsThe states contended that Abbott and Fournier also filed more than a dozen lawsuits against generic drug manufacturers Teva Pharmaceuticals and Impax Laboratories because the law prohibits the FDA from approving a generic drug for 30 months after patent-infringementlawsuits have been filed. [read post]
Trade Regulation Talk - http://traderegulation.blogspot.com/
De novo review redux — Supreme Court to consider standard of appellate review of patent claim construction
4 Apr 2014, 12:00 pm by Martin Miller
Teva Pharmaceuticals USA, Inc. v. [read post]
Technology Law Source - http://www.technologylawsource.com/
CAFC Says Appellate Review of PTAB Institution Denials is Limited to ‘Extraordinary Circumstances’
16 Mar 2021, 1:15 pm by Logan Murr
In opposition to the institution of the IPR, Janssen Pharmaceuticals argued that the IPR “would be an inefficient use of Board resources,” due to two co-pending district court cases: the suit against Mylan Laboratories and another against Teva Pharmaceuticals, arguing “that both actions would likely reach final judgment before any IPR final written decision. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Judge Newman's Suit Continues
28 Apr 2024, 8:18 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Special Committee of the Judicial Council of the Federal Circuit Replies
27 May 2024, 9:26 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Inducing Infringement by Making a Product Available
6 Oct 2020, 8:19 am by Dennis Crouch
Teva Pharmaceuticals (Fed. [read post]
Patently-O - http://patentlyo.com/patent
SUPREME COURT: PATENT CLAIM CONSTRUCTION – TWO STANDARDS OF REVIEW
13 Mar 2015, 3:25 pm by Audrey A Millemann
  In Teva Pharmaceuticals USA, Inc. v. [read post]
IP Law Blog - http://www.theiplawblog.com/
Drug companies accused of conspiracy to raise prices
14 May 2019, 7:50 am by Matthew Borges
The complaint was filed in the District Court for the District of Connecticut and names Teva Pharmaceuticals along with 19 other companies and 15 individuals who are senior executives at the heart of the scandal. [read post]
JURIST - Paper Chase - http://www.jurist.org/paperchase/